Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909]
Titel:
Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909]
Auteur:
Wronski, Marie-Louis Plessow, Franziska Kerem, Liya Asanza, Elisa O'Donoghue, Michelle L. Stanford, Fatima C. Bredella, Miriam A. Torriani, Martin Soukas, Alexander A. Kheterpal, Arvin Eddy, Kamryn T. Holmes, Tara M. Deckersbach, Thilo Vangel, Mark Holsen, Laura M. Lawson, Elizabeth A.